Relacin, a novel antibacterial agent targeting the Stringent Response.

Finding bacterial cellular targets for developing novel antibiotics has become a major challenge in fighting resistant pathogenic bacteria. We present a novel compound, Relacin, designed to inhibit (p)ppGpp production by the ubiquitous bacterial enzyme RelA that triggers the Stringent Response. Rela...

Full description

Saved in:
Bibliographic Details
Main Authors: Ezequiel Wexselblatt, Yaara Oppenheimer-Shaanan, Ilana Kaspy, Nir London, Ora Schueler-Furman, Eylon Yavin, Gad Glaser, Joshua Katzhendler, Sigal Ben-Yehuda
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2012
Subjects:
Online Access:https://doaj.org/article/d1f6e73e68eb43c99e4dd57e26c58e24
Tags: Add Tag
No Tags, Be the first to tag this record!